On 1 July 2021 the new European Pharmacopoeia (Ph.Eur.) Chapter 2.1.7 "Balances for Analytical Purposes" will be published, and after a transition period of 6 months, become mandatory on 1 January 2022 for pharmaceutical companies manufacturing or exporting into the European market.
The new chapter describes principles for the use of balances used in analytical procedures including calibration and performance checks to maintain the instruments' performance.
Our new white paper summarizes the concepts of the well-known USP Chapters <41> and <1251> and the new European Pharmacopoeia (Ph.Eur.) Chapter 2.1.7.
Complete the Form to Download the White Paper
Download the Infographic
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.